The Lung Cancer Program evaluates and treats patients with known or suspected lung tumors and severe emphysema.  Each week, a team of thoracic surgeons, medical oncologists, pathologists, radiation oncologists and other experts reviews each patient's case and provides a personalized treatment plan.

If you've been diagnosed with lung cancer, or suspect you may have it, please call 734-647-8902.

If you're referring a patient, please contact M-Line 800-962-3555.

For people with questions, please call our Cancer AnswerLine at 800-865-1125.

There are 3 main subtypes of NSCLC. The cells in these subtypes differ in size, shape, and chemical make-up when looked at under a microscope. But they are grouped together because the approach to treatment and prognosis (outlook) are very similar.

Squamous (epidermoid) cell cancer:
About 25% to 30% of all lung cancers are squamous cell carcinomas. These cancers start in early versions of squamous cells, which are flat cells that line the inside of the airways in the lungs. They are often linked to a history of smoking and tend to be found in the middle of the lungs, near a bronchus.

Adenocarcinoma:
About 40% of lung cancers are adenocarcinomas. These cancers start in early versions of the cells that would normally secrete substances such as mucus. This type of lung cancer occurs mainly in people who smoke (or have smoked), but it is also the most common type of lung cancer seen in non-smokers. It is more common in women than in men, and it is more likely to occur in younger people than other types of lung cancer.

Large cell (undifferentiated) carcinoma:
This type of cancer accounts for about 10% to 15% of lung cancers. It may appear in any part of the lung. It tends to grow and spread quickly, which can make it harder to treat.

Other subtypes
This type of cancer accounts for about 10% to 15% of lung cancers. It may appear in any part of the lung. It tends to grow and spread quickly, which can make it harder to treat.